COMP <GO>
PATH vs QLYS // RETURN ON INVESTED CAPITAL (ROIC)
UiPath Inc. (NYSE) VS. Qualys Inc. (NASDAQ) • 15-METRIC TALLY: PATH 4
— QLYS 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: QLYS
LAST: $13.34 (-2.84%) • MKT CAP: $6.95B
roic
2.70%
LAST: $207.60 (-7.37%) • MKT CAP: $7.18B
roic
27.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PATH VS. QLYS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PATH | QLYS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 83.20% | 82.80% | +0.40 | PATH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 2.70% | 27.50% | -24.80 | QLYS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 92.8x | 35.1x | +57.70 | QLYS | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | 3.82% | +1.08 | PATH | /fcf-yield <GO> |
| Operating Margin | 3.50% | 33.20% | -29.70 | QLYS | /operating-margins <GO> |
| Net Profit Margin | 17.50% | 29.60% | -12.10 | QLYS | /net-margins <GO> |
| Revenue Growth (YoY) | 12.70% | 10.10% | +2.60 | PATH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.25 | 10.23 | -5.98 | QLYS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 50.2 | -5.70 | QLYS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.21 | 1.35 | -0.14 | QLYS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.3x | 37.4x | -16.10 | PATH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.95B | $7.18B | -$229.7M | QLYS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PATH REV | QLYS REV | PATH GROSS % | QLYS GROSS % | PATH FCF | QLYS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.61B | $669.1M | 83.2% | 82.8% | $352.2M | $304.4M |
| FY 2024 | $1.43B | $607.6M | 82.7% | 81.7% | $305.6M | $231.8M |
| FY 2023 | $1.31B | $554.5M | — | — | $240.2M | $219.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PATH // BETA 1.21
QLYS // BETA 1.35